肝性脑病的中西医研究进展
Research Progress in Traditional Chinese and Western Medicine for Hepatic Encephalopathy
DOI: 10.12677/ACM.2023.13102279, PDF,   
作者: 隆 强:新疆医科大学第四临床医学院,新疆 乌鲁木齐;王晓忠*:新疆医科大学附属中医医院,新疆 乌鲁木齐
关键词: 肝性脑病病因病机辨证分型中西医结合治疗Hepatic Encephalopathy Etiology and Pathogenesis Syndrome Differentiation and Classification Combined Treatment of Traditional Chinese Medicine and Western Medicine
摘要: 肝性脑病为肝硬化及门静脉高压最为常见的并发症之一,严重影响患者的生存质量,对于肝性脑病一直以来都是中西医结合研究的重点,中西医均实施了许多的探索,并取得了一定的发展,为肝性脑病在发病机制、诊断、治疗等方面提供了行之有效的临床指导。近年来,肝性脑病的中西医研究取得了长足的进展,本文旨在总结这些研究成果,为未来的研究工作提供指导。
Abstract: Hepatic encephalopathy is one of the most common complications of liver cirrhosis and portal hy-pertension, which seriously affects the quality of life of patients. It has always been a focus of inte-grated traditional Chinese and Western medicine research for hepatic encephalopathy. Both Chi-nese and Western medicine have implemented many explorations and achieved certain develop-ments, providing effective clinical guidance for the pathogenesis, diagnosis, treatment, and other aspects of hepatic encephalopathy. In recent years, significant progress has been made in the re-search of traditional Chinese and Western medicine on hepatic encephalopathy. This article aims to summarize these research results and provide guidance for future research work.
文章引用:隆强, 王晓忠. 肝性脑病的中西医研究进展[J]. 临床医学进展, 2023, 13(10): 16295-16300. https://doi.org/10.12677/ACM.2023.13102279

参考文献

[1] 中华医学会肝病学分会. 肝硬化肝性脑病诊疗指南[J]. 临床肝胆病杂志, 2018, 34(10): 2076-2089. [Google Scholar] [CrossRef
[2] 陆璐, 鲁冰洁, 安永潼, 等. 肝性脑病中西医诊疗进展[J]. 辽宁中医药大学学报, 2019, 21(6): 127-131. [Google Scholar] [CrossRef
[3] 黄云义, 张群, 时克, 等. 中医药治疗肝性脑病的研究进展[J]. 中国中西医结合杂志, 2020, 40(5): 638-640. [Google Scholar] [CrossRef
[4] Weissenborn, K. (2019) Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles. Drugs, 79, 5-9. [Google Scholar] [CrossRef] [PubMed]
[5] Ochoa-Sanchez, R. and Rose, C.F. (2018) Pathogenesis of Hepat-ic Encephalopathy in Chronic Liver Disease. Journal of Clinical and Experimental Hepatology, 8, 262-271. [Google Scholar] [CrossRef] [PubMed]
[6] Kornerup, L.S., Gluud, L.L., Vilstrup, H. and Dam, G. (2018) Up-date on the Therapeutic Management of Hepatic Encephalopathy. Current Gastroenterology Reports, 20, Article 21. [Google Scholar] [CrossRef] [PubMed]
[7] Wijarnpreecha, K., Chesdachai, S., Thongprayoon, C., et al. (2017) Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy. Digestive Diseases and Sciences, 62, 3614-3621. [Google Scholar] [CrossRef] [PubMed]
[8] Ferenci, P. (2017) Hepatic Encephalopathy. Gastro-enterology Report, 5, 138-147. [Google Scholar] [CrossRef] [PubMed]
[9] Bajaj, J.S., Lauridsen, M., Tapper, E.B., et al. (2020) Important Unre-solved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus. The American Journal of Gas-troenterology, 115, 989-1002. [Google Scholar] [CrossRef] [PubMed]
[10] Dhiman, R.K., et al. (2020) Comparative Efficacy of Treat-ment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis. Clinical Gas-troenterology and Hepatology, 18, 800-812. [Google Scholar] [CrossRef] [PubMed]
[11] Yu, X., Jin, Y., Zhou, W.X., et al. (2021) Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis without Impacting the Resistome. Frontiers in Cellular and Infection Microbiology, 11, Article 761192. [Google Scholar] [CrossRef] [PubMed]
[12] 余芳杰. 乳果糖联合双歧杆菌三联活菌胶囊在轻微性肝性脑病患者中的应用效果[J]. 中国微生态学杂志, 2020, 32(8): 929-932. [Google Scholar] [CrossRef
[13] 刘荣明, 李亮, 解君挺. 双歧杆菌四联活菌片联合乳果糖对轻微型肝性脑病患者炎症性肠黏膜损伤的保护作用[J]. 中国微生态学杂志, 2021, 33(10): 1181-1184. [Google Scholar] [CrossRef
[14] Zhao, L.N.,Yu, T.,Lan, S.Y., et al. (2015) Probiotics Can Im-prove the Clinical Outcomes of Hepatic Encephalopathy: An Update Meta-Analysis. Clinics and Research in Hepatology and Gastroenterology, 39, 674-682. [Google Scholar] [CrossRef] [PubMed]
[15] 徐小元, 等. 肝硬化肝性脑病诊疗指南[J]. 西南医科大学学报, 2018, 41(6): 477-490.
[16] Rahimi, R.S. and Rockey, D.C. (2015) Novel Ammonia-Lowering Agents for Hepatic Encephalopathy. Clinics in Liver Disease, 19, 539-549. [Google Scholar] [CrossRef] [PubMed]
[17] Bombassaro, I.Z., et al. (2021) Albumin in the Management of Hepatic Encephalopathy: A Systematic Review and Meta-Analysis. Annals of Hepatology, 26, Article ID: 100541. [Google Scholar] [CrossRef] [PubMed]
[18] Bajaj, J.S., et al. (2017) Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial. Hepatology, 66, 1727-1738. [Google Scholar] [CrossRef] [PubMed]
[19] 于冰雪, 吴健林, 吴继周, 等. 血浆置换对肝性脑病患者血锰水平的影响[J]. 临床肝胆病杂志, 2015, 31(8)  : 1311-1313.
[20] 李晶滢, 辛喜艳, 杨华升. 钱英辨治轻微型肝性脑病经验[J]. 中华中医药杂志, 2021, 36(7): 4022-4024.
[21] 李峰, 来杰锋, 傅燕燕, 等. 施维群运用“辛开苦降法”治疗肝性脑病经验[J]. 浙江中西医结合杂志, 2019, 29(11): 875-876. [Google Scholar] [CrossRef
[22] 姜婷婷, 杨志云, 江宇泳, 等. 轻微型肝性脑病的发病危险因素及中医证型分布规律[J]. 北京中医药, 2019, 38(3): 211-215. [Google Scholar] [CrossRef
[23] 段秋雯. 桃核承气汤治疗轻微型肝性脑病(瘀热互结证)的临床观察[D]: [硕士学位论文]. 长春: 长春中医药大学, 2019.
[24] 范铭兴, 张曾娣, 缪红军. 安宫牛黄丸联合醒脑静注射液治疗肝性脑病临床观察[J]. 中华中医药学刊, 2020, 38(2): 237-240. [Google Scholar] [CrossRef
[25] 周伟. 中西医结合疗法救治肝硬化合并肝性脑病的临床观察[J]. 中国医药指南, 2020, 18(13): 190-191.
[26] 闫建汶. 醒脑静注射液联合还原型谷胱甘肽对肝性脑病病人IL-6和IL-18表达的影响[J]. 中西医结合心脑血管病杂志, 2018, 16(6): 827-829.
[27] 李媛媛. 解毒通络开窍方联合董氏奇穴治疗肝性脑病的临床观察[D]: [硕士学位论文]. 郑州: 河南中医药大学, 2018.
[28] 苏会玲, 苏红慧, 崔厚松, 等. 针刺十三鬼穴对肝性脑病患者血氨、β内啡肽水平的影响[J]. 吉林中医药, 2017, 37(10): 1049-1052.
[29] 常玉坤, 刘亚爽, 石志敏. 人中透刺龈交穴联合西药治疗肝性脑病的临床观察[J]. 世界中西医结合杂志, 2018, 13(5): 646-648.